Margarita Calonge
Margarita Calonge
Afiliación desconocida
No hay ninguna dirección de correo electrónico verificada.
Citado por
Citado por
Referral patterns of uveitis in a tertiary eye care center
A Rodriguez, M Calonge, M Pedroza-Seres, YA Akova, EM Messmer, ...
Archives of Ophthalmology 114 (5), 593-599, 1996
Applications of nanoparticles in ophthalmology
Y Diebold, M Calonge
Progress in retinal and eye research 29 (6), 596-609, 2010
Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease
A Enríquez-de-Salamanca, E Castellanos, ME Stern, I Fernández, ...
Molecular vision 16, 862, 2010
Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting
C Baudouin, P Aragona, EM Messmer, A Tomlinson, M Calonge, ...
The ocular surface 11 (4), 246-258, 2013
Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance
AE De Salamanca, Y Diebold, M Calonge, C García-Vazquez, S Callejo, ...
Investigative ophthalmology & visual science 47 (4), 1416-1425, 2006
The treatment of dry eye
M Calonge
Survey of ophthalmology 45, S227-S239, 2001
Ocular surface alteration after long-term treatment with an antiglaucomatous drug
JM Herreras, JC Pastor, M Calonge, VM Asensio
Ophthalmology 99 (7), 1082-1088, 1992
Ocular drug delivery by liposome–chitosan nanoparticle complexes (LCS-NP)
Y Diebold, M Jarrín, V Sáez, ELS Carvalho, M Orea, M Calonge, B Seijo, ...
Biomaterials 28 (8), 1553-1564, 2007
Atopic keratoconjunctivitis
CS Foster, M Calonge
Ophthalmology 97 (8), 992-1000, 1990
Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007)
AJ Bron, MB Abelson, G Ousler, E Pearce, A Tomlinson, N Yokoi, ...
Ocular Surface 5 (2), 108-152, 2007
Impression cytology of the ocular surface: a review
M Calonge, Y Diebold, V Sáez, AE de Salamanca, C Garcı́a-Vázquez, ...
Experimental eye research 78 (3), 457-472, 2004
Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva
Y Diebold, M Calonge, AE de Salamanca, S Callejo, RM Corrales, V Sáez, ...
Investigative ophthalmology & visual science 44 (10), 4263-4274, 2003
Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A
P Calvo, A Sánchez, J Martínez, MI López, M Calonge, JC Pastor, ...
Pharmaceutical research 13 (2), 311-315, 1996
Ebulin 1, a nontoxic novel type 2 ribosome-inactivating protein from Sambucus ebulus L. leaves.
T Girbes, L Citores, R Iglesias, JM Ferreras, R Munoz, MA Rojo, FJ Arias, ...
Journal of Biological Chemistry 268 (24), 18195-18199, 1993
Epidermal growth factor and corneal wound healing: a multicenter study
JC Pastor, M Calonge
Cornea 11 (4), 311-314, 1992
Dry eye disease as an inflammatory disorder
M Calonge, A Enríquez-de-Salamanca, Y Diebold, MJ González-García, ...
Ocular immunology and inflammation 18 (4), 244-253, 2010
Autoimmunity at the ocular surface: pathogenesis and regulation
ME Stern, CS Schaumburg, R Dana, M Calonge, JY Niederkorn, ...
Mucosal immunology 3 (5), 425-442, 2010
Isolation and partial characterization of nigrin b, a non-toxic novel type 2 ribosome-inactivating protein from the bark ofSambucus nigra L.
T Girbés, L Citores, JM Ferreras, MA Rojo, R Iglesias, R Muñoz, FJ Arias, ...
Plant molecular biology 22 (6), 1181-1186, 1993
Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells
L Contreras-Ruiz, M de la Fuente, JE Párraga, A López-García, ...
Molecular vision 17, 279, 2011
Pars planitis: epidemiology, treatment, and association with multiple sclerosis
JF Prieto, E Dios, JM Gutierrez, A Mayo, M Calonge, JM Herreras
Ocular immunology and inflammation 9 (2), 93-102, 2001
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20